NRXP·629444209·US·equity·Healthcare - Biotechnology-13D/G
NRXP (NRX PHARMACEUTICALS INC) is held by 17 institutional investors as of Q1 2026. Largest holders: COMMONWEALTH EQUITY SERVICES, LLC ($846,530), GEODE CAPITAL MANAGEMENT, LLC ($660,609), BlackRock, Inc. ($210,860). Net institutional sentiment: Bullish.
See how NRXP's score breaks down across 4 SEC sources
Showing 1-20 of 20
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer